Heska First Quarter 2019 Results and Conference Call Scheduled for May 7, 2019

April 16, 2019 |

1 min read

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2019 financial results in a press release on Tuesday, May 7, 2019 before the market opens and to host a conference call on the results at 9 a.m. MT / 11 a.m. ET on the same day.

LOVELAND, Colo., April 16, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2019 financial results in a press release on Tuesday, May 7, 2019 before the market opens and to host a conference call on the results at 9 a.m. MT / 11 a.m. ET on the same day.

Heska Corporation (PRNewsfoto/Heska Corporation)

To access the conference call:
From within the United States, please dial 1-800-263-0877
From outside of the United States, please dial 1-646-828-8143
Reference Conference ID: 7378088

The conference call will be webcast live from the Company’s website on www.heska.com.

A telephonic replay will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Tuesday, May 14, 2019. The webcast will be archived on www.heska.com for 90 days.

To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7378088

About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments; Core Companion Animal Health (“CCA”) represents approximately 85% of revenues, and Other Vaccines, Pharmaceuticals and Products (“OVP”) segment represents approximately 15% of revenues. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health. For further information on Heska and its products, visit www.heska.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-first-quarter-2019-results-and-conference-call-scheduled-for-may-7-2019-300832603.html